Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Thoracic Cancer|February 13, 2025
Detection of Overlooked Rare EGFR Mutations in Non-small Cell Lung Cancer Using Multigene TestingNaoki Shiraishi, Takayuki Takahama, Kazuko Sakai, et al.
Clinical Lung Cancer|June 21, 2023
Alternating Therapy With Osimertinib and Afatinib Blockades EGFR Secondary Mutation in EGFR-Mutant Lung Cancer: A Single-Arm Phase II TrialKimio Yonesaka, Hidetoshi Hayashi, Atsushi Nakamura, et al.
Lung Cancer (Amsterdam, Netherlands)|April 27, 2022
Alternating therapy with osimertinib and afatinib for treatment-naive patients with EGFR-mutated advanced non-small cell lung cancer: A single-group, open-label phase 2 trial (WJOG10818L)Hidetoshi Hayashi, Kimio Yonesaka, Atsushi Nakamura, et al.
Cancer Research|September 26, 2013
Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerizationJeonghee Cho, Liang Chen, Naveen Sangji, et al.
Scientific Reports|August 7, 2019
A comparative study of curated contents by knowledge-based curation system in cancer clinical sequencingKazuko Sakai, Masayuki Takeda, Shigeki Shimizu, et al.
Targeted Oncology|September 22, 2020
Early Tumor Shrinkage and Depth of Response in the Second-Line Treatment for KRAS exon2 Wild-Type Metastatic Colorectal Cancer: An Exploratory Analysis of the Randomized Phase 2 Trial Comparing Panitumumab and Bevacizumab in Combination with FOLFIRI (WJOG6210G)Naoki Izawa, Kohei Shitara, Kimio Yonesaka, et al.
Cancer|February 2, 2016
Bevacizumab beyond disease progression after first-line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non-small cell lung cancer (West Japan Oncology Group 5910L): An open-label, randomized, phase 2 trialMasayuki Takeda, Takeharu Yamanaka, Takashi Seto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in patients with locally advanced NSCLCAtsuto Mouri, Hirotsugu Kenmotsu, Hiroshi Kagamu, et al.
International Journal of Clinical Oncology|January 19, 2011
High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatinYasuhiro Kidera, Taroh Satoh, Shinya Ueda, et al.
Cells|March 26, 2025
Chromosomal Instability Is Associated with cGAS-STING Activation in EGFR-TKI Refractory Non-Small-Cell Lung CancerKimio Yonesaka, Takashi Kurosaki, Junko Tanizaki, et al.
Pageof 7